Department of Pharmacology and Therapeutics, School of Medicine, Trinity College, Dublin, Ireland.
Drug Test Anal. 2013 Aug;5(8):683-92. doi: 10.1002/dta.1456. Epub 2013 Jan 11.
The synthetic cannabinoid, UR-144 ((1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone), was identified in commercial 'legal high' products (herbal, resin, and powder). Along with this, six related compounds were detected. The most abundant one (2.1) was identified as 4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-one, a product of the electrophilic addition of water to the cyclopropane moiety in UR-144. Compound 2.1 was found to be undergo cyclisation which leads to the formation of two additional interconvertable compounds (2.3, tentatively identified as 1-pentyl-3-(4,4,5,5-tetramethyl-4,5-dihydrofuran-2-yl)-1H-indole which is stable only in absence of water and also observed as GC artifact) and 2.2, a protonated derivative of 2.3 which is formed in acidic solutions. The remaining compounds were identified as possible degradation products of the group 2 compounds (4,4,5,5-tetramethyldihydrofuran-2(3H)-one and 1-pentylindoline-2,3-dione) and intermediates or by-products from the synthesis of UR-144 ((1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, 1-pentyl-1H-indole and 1-(1-pentyl-1H-indol-3-yl)hexan-1-one). Pyrolysis of herbal products containing the group 2 compounds or UR-144 resulted in the formation of 3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pent-4-en-1-one (3). This was confirmed by separate pyrolysis of 2.1 and UR-144. Also, the two additional minor compounds, 1-(1-pentyl-1H-indol-3-yl)ethanone and 1-(1-pentyl-1H-indol-3-yl)propan-1-one, were detected. Pathways for these transformations are presented.
合成大麻素 UR-144((1-戊基-1H-吲哚-3-基)(2,2,3,3-四甲基环丙基)甲酮)已在商业“合法兴奋剂”产品(草药、树脂和粉末)中被发现。同时,还检测到了六种相关化合物。最丰富的一种(2.1)被鉴定为 4-羟基-3,3,4-三甲基-1-(1-戊基-1H-吲哚-3-基)戊烷-1-酮,这是 UR-144 中环丙基部分发生亲电加成反应的产物。发现化合物 2.1 会发生环化反应,导致形成另外两种可相互转化的化合物(2.3,推测为 1-戊基-3-(4,4,5,5-四甲基-4,5-二氢呋喃-2-基)-1H-吲哚,该化合物仅在无水条件下稳定,也被观察为 GC 伪影)和 2.2,即 2.3 的质子化衍生物,在酸性溶液中形成。其余化合物被鉴定为 2 类化合物(4,4,5,5-四甲基二氢呋喃-2(3H)-酮和 1-戊基吲哚啉-2,3-二酮)的可能降解产物,以及 UR-144((1H-吲哚-3-基)(2,2,3,3-四甲基环丙基)甲酮、1-戊基-1H-吲哚和 1-(1-戊基-1H-吲哚-3-基)己烷-1-酮)合成的中间体或副产物。含有 2 类化合物或 UR-144 的草药产品的热解导致 3,3,4-三甲基-1-(1-戊基-1H-吲哚-3-基)戊-4-烯-1-酮(3)的形成。这通过单独对 2.1 和 UR-144 的热解得到了证实。此外,还检测到了另外两种少量的化合物 1-(1-戊基-1H-吲哚-3-基)乙酮和 1-(1-戊基-1H-吲哚-3-基)丙-1-酮。提出了这些转化的途径。